Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-16

Clinical Trial Update: Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer

View source ↗

Summary

A feasibility study evaluating gene alteration analysis using samples obtained by EBUS-TBNA in patients with lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Lung Cancer | Status: RECRUITING